Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The price of Neumora Therapeutics Inc. (NASDAQ: NMRA) closed at $14.74 in the last session, up 1.24% from day before closing price of $14.56. In other words, the price has increased by $1.24 from its previous closing price. On the day, 1.33 million shares were traded. NMRA stock price reached its highest trading level at $15.0 during the session, while it also had its lowest trading level at $14.275.
Ratios:
We take a closer look at NMRA’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 17.22 and its Current Ratio is at 17.22. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, H.C. Wainwright on October 01, 2024, initiated with a Buy rating and assigned the stock a target price of $30.
On July 22, 2024, Needham started tracking the stock assigning a Buy rating and target price of $23.
On July 08, 2024, Mizuho started tracking the stock assigning a Outperform rating and target price of $20.Mizuho initiated its Outperform rating on July 08, 2024, with a $20 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Sep 17 ’24 when Lenz Robert A. sold 30,788 shares for $11.81 per share. The transaction valued at 363,736 led to the insider holds 339,205 shares of the business.
Lenz Robert A. sold 10,676 shares of NMRA for $129,091 on Sep 18 ’24. The Head of R&D now owns 328,529 shares after completing the transaction at $12.09 per share. On Sep 18 ’24, another insider, Lenz Robert A., who serves as the Officer of the company, bought 10,676 shares for $12.09 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, NMRA now has a Market Capitalization of 2358812672 and an Enterprise Value of 1990776960.
Stock Price History:
Over the past 52 weeks, NMRA has reached a high of $21.00, while it has fallen to a 52-week low of $8.33. The 50-Day Moving Average of the stock is 21.42%, while the 200-Day Moving Average is calculated to be 14.67%.
Shares Statistics:
According to the various share statistics, NMRA traded on average about 703.70K shares per day over the past 3-months and 822730 shares per day over the past 10 days. A total of 158.83M shares are outstanding, with a floating share count of 54.90M. Insiders hold about 65.69% of the company’s shares, while institutions hold 27.61% stake in the company. Shares short for NMRA as of 1726185600 were 9523723 with a Short Ratio of 13.53, compared to 1723680000 on 9601726. Therefore, it implies a Short% of Shares Outstanding of 9523723 and a Short% of Float of 11.350001.
